Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
Portfolio Pulse from Benzinga Insights
RxSight (NASDAQ:RXST) has received mixed analyst ratings, with 4 bullish and 2 somewhat bullish ratings in the last 30 days. Analysts have lowered their average 12-month price target by 11.81%, now averaging $63.5. The company's financials show strong revenue growth but weak profitability metrics.
August 06, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RxSight has received mixed analyst ratings with a recent decrease in the average price target by 11.81%. The company shows strong revenue growth but faces challenges in profitability and returns.
The mixed analyst ratings and the decrease in the average price target suggest a cautious outlook. While the company shows strong revenue growth, its weak profitability metrics and lowered price targets indicate potential challenges ahead.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100